Search results
Results from the WOW.Com Content Network
Astra AB was founded in 1913 in Södertälje, Sweden, by 400 doctors and apothecaries. [14] In 1993 the British chemicals company ICI (established from four British chemical companies) demerged its pharmaceuticals businesses and its agrochemicals and specialities businesses, to form Zeneca Group PLC. [15]
Astra AB was a former international pharmaceutical company headquartered in Södertälje, Sweden. Astra was formed in 1913 and merged with the British Zeneca Group in 1999 to form AstraZeneca. [1] Product development was focused on therapeutics for gastrointestinal, cardiovascular and respiratory disorders and pain control. At the time of the ...
The University of Santo Tomas Faculty of Pharmacy is the pharmaceutical school of the University of Santo Tomas, the oldest and the largest Catholic university in Manila, Philippines. Established in 1871, the faculty is the first school of pharmacy in the Philippines.
Alexion Pharmaceuticals was founded in 1992 at Science Park in New Haven, Connecticut by Steven Squinto and Leonard Bell, a physician at Yale New Haven Hospital and assistant professor of medicine and pathology at Yale School of Medicine. [3] [4] In 2000, Alexion moved its headquarters from New Haven to Cheshire, Connecticut. [5] [6]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Astellas Pharma office in Canada. Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社 ...
Also in November, the Philippines agreed to buy 2.6 million doses, [259] reportedly worth around ₱700 million (approximately US$5.60 per dose). [288] In December 2020, South Korea signed a contract with AstraZeneca to secure 20 million doses of its vaccine, reportedly equivalent in worth to those signed by Thailand and the Philippines, [ 260 ...
Pangalos was the Vice President of Neuroscience Research at American pharmaceutical company Wyeth from 2003 to 2008. He was responsible for overseeing the transition of more than 20 novel drug candidates into clinical development for a number of neurological and psychiatric diseases including Alzheimer's disease, stroke, schizophrenia, and pain.